Patents by Inventor Heeren M. Gordhan

Heeren M. Gordhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZETIDINYL PYRIMIDINES AND USES THEREOF
    Publication number: 20240425496
    Abstract: Provided herein are azetidine pyrimidine compounds. In particular, provided herein are compounds that affect the function of kinases in a cell, and that are useful as therapeutic agents or with therapeutic agents. The compounds provided herein are useful in the treatment of a variety of diseases and conditions including inflammatory eye diseases such as uveitis, cardiovascular diseases, inflammatory diseases, and diseases characterized by abnormal growth, such as cancers. Also provided herein are compositions comprising azetidine pyrimidine compounds.
    Type: Application
    Filed: July 1, 2022
    Publication date: December 26, 2024
    Inventors: David Archer Ellis, Heeren M. Gordhan, Cynthia L. Lichorowic, Jill M. Sturdivant, Mitchell A. deLong, Casey Kopczynski, Jeffrey C. White, Michelle Senchyna, David Hollander
  • N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
    Publication number: 20240360075
    Abstract: Described herein are modified monoterpene TRPM8 activating compounds. In particular, provided herein are compounds that affect the function of ion channels in a cell, and are useful as therapeutic agents or with therapeutic agents. The compounds provided herein are useful in the treatment of a variety of diseases and conditions including inflammatory eye diseases such as uveitis, cardiovascular diseases, inflammatory diseases, and diseases characterized by abnormal growth, such as cancers.
    Type: Application
    Filed: April 19, 2024
    Publication date: October 31, 2024
    Inventors: Heeren M. Gordhan, Mitchell A. deLong, Jill M. Sturdivant, David Archer Ellis, Cynthia L. Lichorowic
  • Azetidinyl Pyrimidines and Uses Thereof
    Publication number: 20240002392
    Abstract: Provided herein are compounds useful as inhibitors of Janus kinase (JAK) proteins and in treating JAK-related diseases.
    Type: Application
    Filed: June 29, 2023
    Publication date: January 4, 2024
    Inventors: David Archer Ellis, Heeren M. Gordhan, Cynthia L. Lichorowic, Jill M. Sturdivant, Mitchell A. deLong
  • HETEROBICYCLIC CARBOXAMIDES AND USES THEREOF
    Publication number: 20230002404
    Abstract: Provided herein are heterobicyclic cyclopropanecarboxamide and heterobicyclic carboxamide compounds. In particular, provided herein are compounds that affect the function of kinases in a cell, and that are useful as therapeutic agents or with therapeutic agents. The compounds provided herein are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, inflammatory diseases, and diseases characterized by abnormal growth, such as cancers. Also provided herein are compositions comprising heterobicyclic cyclopropanecarboxamide or heterobicyclic carboxamide compounds.
    Type: Application
    Filed: September 11, 2020
    Publication date: January 5, 2023
    Inventors: Mitchell A. deLong, Jill M. Sturdivant, Cynthia L. Lichorowic, Heeren M. Gordhan